Influence Of Cmtm8 Polymorphisms On Lung Cancer Susceptibility In The Chinese Han Population

Jiamin Wu,Yao Sun,Zichao Xiong,Fanglin Niu,Yuanwei Liu,Haiyue Li,Jianfeng Liu,Junsheng Wu,Qiufang Liu,Tianbo Jin
DOI: https://doi.org/10.1097/FPC.0000000000000426
2021-01-01
Pharmacogenetics and Genomics
Abstract:BackgroundLung cancer is the leading cause of cancer-related mortality worldwide and CMTM8 is a potential tumor suppressor gene, which is down-regulated in lung cancer. The objective of this research was to assess the association of CMTM8 genetic polymorphisms with lung cancer risk.MethodsTo evaluate the correlation between CMTM8 polymorphisms and lung cancer risk, Agena MassArray platform was used for genotype determination among 509 lung cancer patients and 506 controls. Multiple genetic models, stratification analysis and Haploview analysis were used by calculating odds ratio (OR) and 95% confidence intervals (CIs).ResultsSignificant associations were detected between CMTM8 rs6771238 and an increased lung cancer risk in codominant (adjusted OR = 1.57, 95% CI: 1.01-2.42, P = 0.044) and dominant (adjusted OR = 1.54, 95% CI: 1.01-2.36, P = 0.047) models. After sex stratification analysis, we observed that rs6771238 was related to an increased risk of lung squamous cell carcinoma, while rs6771238 was associated with an increased risk of lung adenocarcinoma. Rs9835916 was linked to increased risk of lymph node metastasis in lung cancer patients.ConclusionOur study first reported that CMTM8 polymorphisms were a risk factor for lung cancer, which suggested the potential roles of CMTM8 in the development of lung cancer.
What problem does this paper attempt to address?